Dr. Perry G. Wang
is a chemist in the Office of Regulatory Science, US Food and Drug
Administration (US FDA). His interests include analytical method development and validation for drugs and constituents of foods and cosmetic products using advanced instrumentation. His expertise focuses on high throughput drug analysis by LC/MS/MS for the pharmaceutical industry.
In addition to numerous peer-reviewed papers, he has recently published three books: Hydrophilic Interaction Liquid Chromatography and Advanced Applications (ISBN: 978-1-4398-0753-8) was published by CRC Press in March 2011; Monolithic Chromatography and Its Modern Applications (ISBN: 978-1-906799-03-8) was published by ILM Publications in September 2010; High-Throughput Analysis in the Pharmaceutical Industry (ISBN: 978-1-4200-5953-3) was published by CRC Press in October 2008. He is currently editing another
book entitled Identification and Analysis of Counterfeit and Substandard Pharmaceuticals with ILM Publications, which is scheduled for publication in October 2011.
He has prepared, organized and presided over symposia for the Pittsburg Conference (PittCon) since 2006. He has been an invited speaker since 2004 at international conferences including the PittCon; Federation of Analytical Chemistry and Spectroscopy Societies (FACSS); Beijing Conference and Exhibition on Instrumental Analysis (BCEIA) and International Symposium on Chemical Biology and Combinatorial Chemistry (ICCBCC). He has been invited to teach short
courses for the PittCon, the American Chemistry Society (ACS), Eastern Analytical Symposium (EAS) and Calibration and Validation Group (Canada). His current research focuses on developing analytical methods for constituents of cosmetics and dietary supplements.
Dr. Wang received his B.S. degree in Chemistry from Shandong University. He earned his M.S. and Ph.D. degrees in Environmental Engineering from Oregon State University, in Corvallis, Oregon, USA.